This HTML5 document contains 99 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0028640/
n14http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0028640/core-reimbursement/
n15http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0028640/price/
n3http://linked.opendata.cz/ontology/sukl/
skoshttp://www.w3.org/2004/02/skos/core#
n7http://linked.opendata.cz/resource/sukl/indgroup/
n4http://linked.opendata.cz/resource/sukl/packing/
n6http://linked.opendata.cz/resource/sukl/company/
n5http://linked.opendata.cz/resource/sukl/active-ingredient/
n16http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/sukl/registration-state/
n8http://www.emea.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000783/
n9http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0028640/price-of-originator/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0028640/reimbursement/
n20http://linked.opendata.cz/resource/atc/
n18http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item
n2:0028640
rdf:type
n3:MedicinalProductPackaging
dcterms:title
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300 MG/12,5 MG
skos:notation
0028640
n3:hasATCCode
n20:C09DA04
n3:hasActiveIngredient
n5:HYDROCHLOROTHIAZIDUM n5:IRBESARTANUM
n3:hasDefinedDailyDose
n11:ddd
n3:hasDosageForm
n18:TBL-NOB-POR
n3:hasPackagingSize
28
n3:hasPacking
n4:BLI
n3:hasRegistrationHolder
n6:SGXF
n3:hasRegistrationState
n10:R
n3:hasRouteOfAdministration
n14:POR
n3:hasStrength
300MG/12.5MG
n3:hasIndicationGroup
n7:58
n3:hasSpecializationRestriction
n16:blank-cell
n3:containsDefinedDailyDoses
28.0
n3:hasRegistrationCode
EU/1/06/377/007
n3:hasTitleSupplement
POR TBL NOB 28
n3:containsUsualTherapeuticalDailyDoses
35
n3:hasCoreReimbursementSpecification
n12:2013-10-01 n12:2013-11-01 n12:2013-08-03 n12:2013-09-01 n12:2013-07-01 n12:2013-08-01 n12:2013-05-01 n12:2013-06-01 n12:2014-04-01 n12:2014-05-01 n12:2014-02-01 n12:2014-03-01 n12:2013-12-01 n12:2014-01-01 n12:2013-03-01 n12:2013-04-01 n12:2013-01-05 n12:2013-02-01 n12:2013-01-01
n3:hasPriceOfOriginatorSpecification
n9:2013-01-01 n9:2013-01-05 n9:2013-11-01 n9:2013-12-01 n9:2013-09-01 n9:2013-10-01 n9:2014-03-01 n9:2014-04-01 n9:2014-01-01 n9:2014-02-01 n9:2013-04-01 n9:2013-05-01 n9:2013-02-01 n9:2013-03-01 n9:2013-08-01 n9:2013-08-03 n9:2013-06-01 n9:2013-07-01 n9:2014-05-01
n3:hasPriceSpecification
n15:2013-10-01 n15:2013-11-01 n15:2013-12-01 n15:2014-01-01 n15:2013-07-01 n15:2013-08-01 n15:2013-08-03 n15:2013-09-01 n15:2013-03-01 n15:2013-04-01 n15:2013-05-01 n15:2013-06-01 n15:2013-01-01 n15:2013-01-05 n15:2013-02-01 n15:2014-02-01 n15:2014-03-01 n15:2014-04-01 n15:2014-05-01
n3:hasReimbursementSpecification
n17:2013-09-01 n17:2013-10-01 n17:2013-08-01 n17:2013-08-03 n17:2013-06-01 n17:2013-07-01 n17:2013-04-01 n17:2013-05-01 n17:2013-02-01 n17:2013-03-01 n17:2013-01-01 n17:2013-01-05 n17:2014-05-01 n17:2014-03-01 n17:2014-04-01 n17:2014-01-01 n17:2014-02-01 n17:2013-11-01 n17:2013-12-01
n3:hasUsualTherapeuticalDailyDose
n11:utdd
n3:spcFile
http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000783%2FWC500035545.pdf
n3:spcUri
n8:WC500035545.pdf